Vascular Grafts Market By Type (Endovascular Stent Grafts, Peripheral Vascular Grafts, Hemodialysis Access Grafts, Coronary Artery By-Pass Grafts), By Material (Synthetic, Biological, Biosynthetic), By Application (Cardiovascular Diseases, Aneurysm, Kidney Failure, Vascular Occlusion) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

The purpose of this research study titled "Vascular Grafts Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global vascular grafts market. This report presents and analyses the major trends prevalent in the global vascular grafts market and the market's size and forecast.

This report categorizes the global vascular grafts market in terms of type, material, application, and geographical distribution. Based on product type, the global vascular grafts market is categorized into endovascular stent grafts, peripheral vascular grafts, hemodialysis access grafts, and coronary artery bypass grafts. Synthetic (polytetrafluoroethylene (PTFE), polyurethane (P.U.), dacron, and others), biological (saphenous vein, bovine vein, and others), and biosynthetic are the various vascular graft materials studied in this report. In terms of application areas, vascular grafts find wide usage in the treatment of cardiovascular diseases, aneurysms, kidney failure, vascular occlusion, and diabetes. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

Geographically, the global vascular grafts market is best understood by segmenting it into five major regions and five major region-level markets, as follows:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa
  • GCC
  • Rest of the Middle East and Africa

Each considered geographical market's market size and forecast are presented for the period 2015-2025, along with CAGRs for the forecast period 2017-2025, and are further cross-sectional presented in terms of type, material, application, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global vascular grafts market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the vascular grafts market. The key players profiled in this report are Artegraft, Inc., B. Braun Melsungen AG, Cook Medical, Inc., C.R. Bard, Inc., CryoLife, Inc., Heart Medical Europe B.V., Japan Lifeline Co., Ltd. (Junken Medical Co., Ltd.), LeMaitre Vascular, Inc., MAQUET Holding B.V. & Co. K.G., Medtronic plc, Shanghai Suokang Medical Implants Co. Ltd., Terumo Medical Corporation, Vascular Grafts Solutions Ltd., Vascular Grafts Ltd., Vascular Grafts Ltd.,

The global vascular grafts market is studied for the following material types:

  • Synthetic  
  • Polytetrafluethylene (PTFE)
  • Polyurethane (P.U.)
  • Dacron
  • Others
  • Biological  
  • Saphenous Vein
  • Bovine Vein
  • Others
  • Biosynthetic

Synthetic grafts are currently the most popular type all over the world. Polytetrafluoroethylene, polyurethane, dacron, etc., are highly preferred in the majority of grafting procedures. Easy availability, lesser cost, and higher tensile strength are some of the factors attributing to the larger market share of synthetic materials. However, biological materials have a higher demand in cardiovascular treatments and are expected to be the fastest-growing segment. Growing awareness about the benefits of biological grafts in terms of acceptance, biocompatibility, and technological advancement are the key factors contributing to the emergence of biological materials. At present, the internal thoracic artery and saphenous vein are the gold standard grafts used for cardiovascular procedures and outperform synthetic alternatives. However, the limited availability of these grafts challenges their widespread use. To address this challenge, tissue-engineered vascular grafts (TEVG) are being rigorously explored. Benefits of TEVG include the ability to remodel, grow, and repair in vivo without the need for autologous tissue transplant surgery.

The global vascular grafts market is studied for the following graft types:

  • Endovascular Stent Grafts
  • Peripheral vascular grafts
  • Hemodialysis Access Grafts
  • Coronary Artery By-pass Grafts

 In 2016, endovascular stent grafts occupied the largest share of the overall vascular graft market. Major factors influencing its dominance include the growing risk of chronic diseases such as renal conditions, cardiovascular diseases, and diabetes due to lifestyle changes, occupational factors, and dietary habits. Furthermore, the growing prevalence of hypertension and age-related chronic conditions has additionally urged the need for endovascular grafts and coronary artery bypass grafts in the market. Additionally, recent developments in vascular tissue engineering have resulted in the creation of cell-free grafts that are available on demand. However, restraints associated with cell-based grafts, such as cell expansion, long-term bioreactor culture, and cell sourcing, have motivated the introduction of completely cell-free vascular grafts.

The global vascular grafts market is studied for the following application areas:

  • Cardiovascular Diseases
  • Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Diabetes

In 2016, cardiovascular diseases accounted for over 20% of the global vascular grafts market on account of the growing prevalence of hypertension and other age-related cardiovascular diseases, with the highest prevalence of coronary artery diseases. Cardiovascular diseases are often associated with the blockage or narrowing of blood vessels and reduced blood flow. CVD mortality will surpass 23% by 2032, according to projections. Vascular surgery is often recommended for the treatment of CVDs when pharmaceutical administration and dietary and lifestyle modifications prove inadequate. Vascular grafts may be used to bypass or replace damaged vessels. At present, the most favored conduits for cardiovascular grafting are autologous arteries or veins, with the saphenous vein being the most common autograft option. Despite being the gold standard for grafting, saphenous vein grafting presents limited patency. Additionally, synthetic vascular grafts, though available as an alternative to autologous grafts, are used less due to poor patency rates.

Geographically, the global vascular grafts market is cumulative for North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

North America is the largest regional market for vascular grafts and will continue to dominate the global market. The high prevalence of chronic diseases such as diabetes, cardiovascular diseases, and end-stage renal diseases and the corresponding growth in demand for surgical treatments largely contribute to the dominance of the North American market. The existence of a developed healthcare system, favorable reimbursements, and greater awareness about the treatment and management of chronic diseases are major features of the North American market. Additionally, Asia Pacific is anticipated to be the fastest-processing market for vascular grafts during the forecast period. The rapid evolution of healthcare systems, as well as the increasing penetration of major market players, contribute significantly to the movement of the Asia-Pacific market.

The detailed regional classification of the global vascular graft market is as follows:

  • North America (U.S. and Canada)
  • Europe (Germany, U.K., France, and the Rest of Europe)
  • Asia Pacific (China, India, Japan, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (including the Gulf Cooperation Council and the rest of the Middle East and Africa) 

 Frequently Asked Questions:

The market for Vascular Grafts is expected to reach US$ 3,636.9 Mn in 2025.

The Vascular Grafts market is expected to see significant CAGR growth over the coming years, at 4.9%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Artegraft, Inc.,B. Braun Melsungen AG,Cook Medical, Inc.,C.R. Bard, Inc.,CryoLife, Inc. are some of the major players in the global market.



Choose License Type
Trusted By
Published Date:  Jul 2017
Category:  Medical Devices
Report ID:   58546
Report Format:   PDF
Pages:   120
Rating:    4.5 (80)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support